Stocks
ABIOMED (ABMD) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -2.20 | -2.13 | -1.72 | -2.36 | -1.52 | -1.75 | |||
| Changes by years, y/y, % | -2% | -3% | -19% | +37% | -36% | -7.6% | |||
ABIOMED. Debt/EBITDA
ABIOMED. Debt/EBITDA, changes, %
ABIOMED (ABMD) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| Debt/EBITDA | -1.63 | -1.70 | -1.82 | -2.72 | -1.75 | -1.75 | ||
| Changes by years, y/y, % | -28% | -16% | -23% | +107% | +7% | |||
| Changes by quarters, q/q, % | +24% | +4% | +7% | +50% | -36% | |||
